These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration. Nakamura T, Inagaki H, Seto M, Nakamura S. J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598 [Abstract] [Full Text] [Related]
3. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S. Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [Abstract] [Full Text] [Related]
4. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Dong G, Liu C, Ye H, Gong L, Zheng J, Li M, Huang X, Huang X, Huang Y, Shi Y, Yin W, Gao Z. Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449 [Abstract] [Full Text] [Related]
6. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M. Oncology; 2004 Dec; 66(6):476-80. PubMed ID: 15452377 [Abstract] [Full Text] [Related]
7. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Nakamura T, Nakamura S, Yonezumi M, Suzuki T, Matsuura A, Yatabe Y, Yokoi T, Ohashi K, Seto M. Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689 [Abstract] [Full Text] [Related]
8. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ. Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515 [Abstract] [Full Text] [Related]
9. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma. Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M, Masuda H, Ito M, Tanaka S, Yoshihara M, Chayama K. Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974 [Abstract] [Full Text] [Related]
10. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. Takigawa H, Yuge R, Masaki S, Otani R, Kadota H, Naito T, Hayashi R, Urabe Y, Oka S, Tanaka S, Chayama K, Kitadai Y. Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751 [Abstract] [Full Text] [Related]
11. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review. Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T. World J Gastroenterol; 2015 Jul 14; 21(26):8014-20. PubMed ID: 26185372 [Abstract] [Full Text] [Related]
12. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome. Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC. Helicobacter; 2013 Jun 14; 18(3):197-205. PubMed ID: 23305046 [Abstract] [Full Text] [Related]
13. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Nakamura T, Nakamura S, Yokoi T, Suzuki H, Ohashi K, Seto M. Jpn J Cancer Res; 2002 Jun 14; 93(6):677-84. PubMed ID: 12079516 [Abstract] [Full Text] [Related]
14. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs. Iwano M, Okazaki K, Uchida K, Nakase H, Ohana M, Matsushima Y, Inagaki H, Chiba T. J Gastroenterol; 2004 Aug 14; 39(8):739-46. PubMed ID: 15338367 [Abstract] [Full Text] [Related]
15. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Morgner A, Bayerdörffer E, Neubauer A, Stolte M. Gastroenterol Clin North Am; 2000 Sep 14; 29(3):593-607. PubMed ID: 11030075 [Abstract] [Full Text] [Related]
16. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new. Kuo SH, Cheng AL. Hematology Am Soc Hematol Educ Program; 2013 Sep 14; 2013():109-17. PubMed ID: 24319171 [Abstract] [Full Text] [Related]
18. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission]. Kim SJ, Yang S, Min BH, Lee JH, Rhee PL, Rhee JC, Kim JJ. Korean J Gastroenterol; 2010 Feb 14; 55(2):94-9. PubMed ID: 20168055 [Abstract] [Full Text] [Related]